SCHEMBL7303566

SCHEMBL7303566

CCCC[C@@](N)(C(=O)O)C(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C9 P11712 3/20 0.41
TSHR P16473 3/20 0.41
CYP2C19 P33261 3/20 0.41
CYP2D6 P10635 1/20 0.41
NAAA Q02083 2/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 2/20 0.40
GLS O94925 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ASAH1 Q13510 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303556 1.00 KIF11 (0.43) KIF11NPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL7892965 0.76 NPSR1 (0.39) KIF11NPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL27427030 0.75 POLB (0.42) KIF11NPSR1NAAAPOLBALDH1A1
SCHEMBL6716430 0.75 KYNU (0.40) KIF11NPSR1SMN1; SMN2KMT2ATDP1
SCHEMBL14689712 0.73 ARG1 (0.62) CYP1A2ALDH1A1SMN1; SMN2KMT2A
SCHEMBL27350784 0.73 KIF11 (0.42) KIF11NPSR1CYP1A2CYP3A4CYP2C9
SCHEMBL27450995 0.72 RIPK1 (0.41) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL21632771 0.71 CYP1A2 (0.44) NPSR1CYP1A2CYP2C19CYP2D6SMN1; SMN2
SCHEMBL372366 0.71 KIF11 (0.49) KIF11CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL29189077 0.71 LMNA (0.43) CYP3A4TSHRNAAAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed